treosulfan has been researched along with Cancer of Ovary in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (30.30) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, LH; Larsen, ATR; Olesen, KD; Steffensen, KD; Søndergaard, SR | 1 |
| Ammon, A; Becker, M; Chekerov, R; Göhler, T; Heidrich-Lorsbach, E; Hutzschenreuter, U; Kaltenecker, G; Klare, P; Oskay-Özcelik, G; Reichert, D; Sauer, U; Sehouli, J; Vehling-Kaiser, U; Wischnik, A | 1 |
| Lane, G; Montes, A; Seshadri, S; Wuntakal, R | 1 |
| du Bois, A; Gropp, M; Kimmig, R; Kuhn, W; Lück, HJ; Meier, W; Olbricht, S; Pfisterer, J; Reuss, A; Richter, B | 1 |
| Markman, M | 1 |
| Cree, IA; Gabriel, FG; Glaysher, S; Johnson, P; Knight, LA; Narayanan, A; Parker, K; Polak, M; Poole, M | 1 |
| Belau, A; Fuxius, S; Heidrich-Lorsbach, E; Heuser, T; Klare, P; Kölbl, H; Mahner, S; Markmann, S; Oskay-Özcelik, G; Ruhmland, B; Sehouli, J; Sommer, H | 1 |
| Galaup, A; Paci, A | 1 |
| Allerton, R; Cree, IA; Di Nicolantonio, F; Knight, LA; Kurbacher, CM; Lamont, A; Neale, MH; Osborne, RJ; Skailes, GE | 1 |
| Bojko, P; Dirsch, O; Hilger, RA; Ruehm, SG; Scheulen, ME; Seeber, S | 1 |
| Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P | 1 |
| Grove, A; Knudsen, A; Lund, B; Nielsen, K; Soegaard Andersen, E; Svarrer, T; Tetsche, M | 1 |
| Coleman, R; Duncan, I; Graham, JD; Hay, A; Kaye, SB; Ostrowski, J; Parkin, D; Paul, J; Poole, CJ; Reed, NS | 1 |
| Burnett, RD; Marsh, BT | 1 |
| Grönroos, M; Kauppila, A; Kauppila, O; Nieminen, U; Saksela, E; Väyrynen, M | 1 |
| Balducci, L; Khansur, T; Thigpen, JT; Vance, RB | 1 |
| Ernst, P; Ersbøl, J; Hou-Jensen, K; Knudtzon, S; Larsen, MS; Nissen, NI; Pedersen-Bjergaard, J; Rose, C; Sørensen, HM | 1 |
| Havsteen, H; Kamby, C; Keldsen, N; Laursen, L; Madsen, EL; Sandberg, E | 1 |
| Cree, I; Duncan, I; Evans, A; Kurbacher, C; Petty, R | 1 |
| Gropp, M; Hepp, H; Meier, W | 1 |
| Baumgart, J; Hilger, RA; Jacek, G; Kredtke, S; Oberhoff, C; Scheulen, ME; Seeber, S | 1 |
| Thigpen, T | 1 |
| Bauknecht, T; Costa, S; du, BA; Emon, G; Jackisch, C; Lück, HJ; Meier, W; Moebus, V; Olbricht, S; Richter, B; Schroeder, W; Wagner, U | 1 |
| Breidenbach, M; Kurbacher, CM; Mallmann, P; Rein, DT | 1 |
| Prior, J; White, I | 1 |
| Beck, E; Berg, A; Jäger, W; Lang, N; Schuster, M; Wildt, L | 1 |
| Bell, J; Clarke, EA; Day, NE; Høst, H; Kaldor, JM; Karjalainen, S; Mehnert, W; Pedersen, D; Pettersson, F; Prior, P | 1 |
| Barley, VL; Boesen, E; Chawla, SL; Masding, J; Menday, AP; Rostom, AY; Sarkar, TK; White, WF | 1 |
| Grospietsch, G; Hinney, B; Knappe, G; Kühnle, H; Rümelin, B; Temme, D | 1 |
| Aabo, K; Dombernowsky, P; Hald, I; Hansen, HH; Hørbov, S; Lundvall, F; Nielsen, NC; Sørensen, BL; Sørensen, HM | 1 |
| Shershah, S | 1 |
| Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM | 1 |
| Clayton, LA; Duncan, ID | 1 |
4 review(s) available for treosulfan and Cancer of Ovary
| Article | Year |
|---|---|
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Busulfan; Carcinoma, Ovarian Epithelial; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Randomized Controlled Trials as Topic | 2016 |
Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Myeloablative Agonists; Ovarian Neoplasms; Vidarabine; Whole-Body Irradiation | 2013 |
New drugs and experimental approaches in ovarian cancer treatment.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Aziridines; Benzoquinones; Busulfan; Carboplatin; Cisplatin; Estrogen Antagonists; Female; Galactitol; Humans; Ifosfamide; Mitomycins; Organoplatinum Compounds; Ovarian Neoplasms; Prednimustine; Progestins | 1984 |
The role of gemcitabine-based doublets in the management of ovarian carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Topotecan; Vinblastine; Vinorelbine | 2002 |
10 trial(s) available for treosulfan and Cancer of Ovary
| Article | Year |
|---|---|
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekolog
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Survival Rate; Topotecan | 2009 |
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis.
Topics: Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Agents, Alkylating; Busulfan; Constipation; Drug Administration Schedule; Fatigue; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Quality of Life; Recurrence; Surveys and Questionnaires; Treatment Outcome | 2012 |
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Busulfan; CA-125 Antigen; Carboplatin; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Quality of Life; Survival Analysis; Treatment Outcome | 2006 |
A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation.
Topics: Abdomen; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Finland; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Pelvis; Prospective Studies; Random Allocation; Vincristine | 1984 |
Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Busulfan; Carcinoma; Cisplatin; Denmark; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Ovarian Neoplasms; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 1998 |
Treosulfan as an effective second-line therapy in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Busulfan; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate; Treatment Outcome | 1998 |
Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Female; Humans; Leuprolide; Middle Aged; Ovarian Neoplasms; Paclitaxel; Survival Rate | 2002 |
Leukemia following chemotherapy for ovarian cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Case-Control Studies; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Leukemia; Melphalan; Multicenter Studies as Topic; Neoplasms, Multiple Primary; Ovarian Neoplasms; Registries; Risk Factors; Thiotepa | 1990 |
Intravenous treosulfan versus intravenous treosulfan plus cisplatinum in advanced ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Female; Humans; Infusions, Intravenous; Middle Aged; Multicenter Studies as Topic; Ovarian Neoplasms; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Random Allocation | 1985 |
19 other study(ies) available for treosulfan and Cancer of Ovary
| Article | Year |
|---|---|
Treosulfan in platinum-resistant ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Busulfan; Female; Humans; Middle Aged; Ovarian Neoplasms; Survival Analysis; Treatment Outcome | 2021 |
Treosulfan in the Treatment of Advanced Ovarian Cancer - Results of a German Multicenter Non-interventional Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Busulfan; Disease-Free Survival; Female; Humans; Middle Aged; Ovarian Neoplasms | 2015 |
Chemotherapy: Topotecan or treosulfan--that is the question.
Topics: Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Disease-Free Survival; Drug Resistance; Drug Therapy; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Survival Analysis; Time Factors; Topotecan | 2009 |
Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gemcitabine; Humans; Ovarian Neoplasms; Topotecan | 2010 |
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Doxorubicin; Drug Carriers; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Liposomes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Vinblastine; Vinorelbine | 2002 |
Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Alkylating; Busulfan; Combined Modality Therapy; Female; Femur Head Necrosis; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiography | 2003 |
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gefitinib; Gemcitabine; Humans; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Quinazolines; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Uveal Neoplasms | 2004 |
The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Combined Modality Therapy; Denmark; Epithelial Cells; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Survival Rate; Treatment Outcome | 2005 |
Advanced ovarian cancer.
Topics: Alkylating Agents; Busulfan; Female; Humans; Ovarian Neoplasms | 1980 |
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).
Topics: Adult; Aged; Busulfan; Chromosome Aberrations; Female; Humans; Leukemia; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Risk; Time Factors | 1980 |
Drug resistance in ovarian cancer - the role of p53.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Busulfan; Cisplatin; Disease-Free Survival; Drug Resistance, Multiple; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Survival Rate; Tumor Suppressor Protein p53 | 1998 |
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Biological Availability; Busulfan; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2000 |
Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Treatment Failure | 2002 |
Addisonian syndrome associated with treosulfan.
Topics: Addison Disease; Busulfan; Cystadenocarcinoma; Female; Humans; Middle Aged; Ovarian Neoplasms | 1978 |
[Ototoxicity of cisplatin chemotherapy in patients with ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Busulfan; Cisplatin; Dose-Response Relationship, Drug; Female; Hearing Loss, Sensorineural; Humans; Ovarian Neoplasms; Pilot Projects | 1991 |
[Postoperative therapy of epithelial ovarian cancer at the Göttingen University Gynecologic Clinic. A retrospective analysis of 82 patients 1981-1984].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Reoperation | 1986 |
Treatment by combined chemotherapy for recurrent ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Cystadenocarcinoma; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1985 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Leukemia; Lymphoma; Male; Mechlorethamine; Middle Aged; Myeloproliferative Disorders; Nitrosourea Compounds; Ovarian Neoplasms; Preleukemia; Risk; Time Factors | 1985 |
Combination chemotherapy of ovarian carcinoma with cisplatinum and treosulfan--a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Drug Evaluation; Female; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms | 1985 |